We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
OSLO | OncoSil Medical Ltd | 0.002 | 0.001 | 100.00% | 526,135 | 1 |
TSOOA | Tesoro Gold Ltd | 0.01 | 0.005 | 100.00% | 210,000 | 2 |
ESROB | Estrella Resources Limited | 0.002 | 0.001 | 100.00% | 300,000 | 1 |
VRXRA | VRX Silica Limited | 0.002 | 0.001 | 100.00% | 73,124 | 3 |
NNGO | Nexion Group Ltd | 0.002 | 0.001 | 100.00% | 569,841 | 2 |
AEVO | Avenira Limited | 0.002 | 0.001 | 100.00% | 600,000 | 2 |
GMNO | Gold Mountain Limited | 0.002 | 0.001 | 100.00% | 250,500 | 1 |
EXLO | Elixinol Wellness Limited | 0.0015 | 0.0005 | 50.00% | 2,445,450 | 2 |
BLZ | Blaze Minerals Ltd | 0.006 | 0.002 | 50.00% | 3,190,427 | 18 |
MRQ | MRG Metals Ltd | 0.0015 | 0.0005 | 50.00% | 8,833,334 | 5 |
T92O | Terra Uranium Ltd | 0.02 | 0.005 | 33.33% | 7,500 | 1 |
TEL AVIV, Israel, April 18, 2024 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, announced today that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $2.9 million of its ordinary shares (or pre-funded warrants in lieu thereof) in a registered direct offering and warrants to purchase ordinary shares in a concurrent private placement. The combined effective purchase price for one ordinary share (or pre-funded warrant in lieu thereof) and a warrant to purchase one ordinary share will be $0.36.
HONG KONG, April 17, 2024 /PRNewswire/ -- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"), announced today that it voluntarily requested a withdrawal of a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (File No.333-275708, the "Registration Statement") and accordingly cancelled the proposed public offering pursuant to the Registration Statement .
PRINCETON, N.J., April 18, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced the pricing of its public offering of 11,875,000 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 11,875,000 shares of common stock at a combined public offering price of $0.40 per share and accompanying warrant for aggregate gross proceeds of approximately $4.75 million, before deducting placement agent fees and other offering expenses. The warrants ...
Total Revenues Increased 29.8% Year-over-Year for the Fourth Quarter,55.9% Year-over-Year Growth for the Full Year 2023 149 Net New Store Openings During the Fourth Quarter,912 System-Wide Stores at Year-End 2023 18.7 Million Registered Loyalty Members at Year-End,Representing 66.3% Year-over-Year Growth SHANGHAI, China and ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 64,742.08 | 1,231.91 | 1.94% | 1.27T | 9,280,471,049 |
ETH | Ethereum | 3,104.65 | 38.80 | 1.27% | 373.6B | 3,859,514,031 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 573,154,885 |
BNB | Binance Coin | 559.93 | 7.71 | 1.40% | 88.43B | 517,735,036 |
SOL | Solana | 143.78 | 1.69 | 1.19% | 63.33B | 2,822,157,736 |
STETH | stETH | 3,102.13 | 41.19 | 1.35% | 30.44B | 16,059,402 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 1,280,151,864 |
XRP | Ripple | 0.5007 | -0.0023 | -0.46% | 27.32B | 502,026,758 |
TONCOIN | Wrapped TON Coin | 7.02 | 0.509301 | 7.82% | 24.36B | 397,133,262 |
DOGE | Dogecoin | 0.15221 | -0.00015 | -0.10% | 21.79B | 945,364,626 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions